Related Experiment Videos
Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress
R P Kedar1, D Cosgrove, V R McCready
1Royal Marsden Hospital, Surrey, England.
Radiology
|March 1, 1996
Summary
New microbubble contrast agents for ultrasound (US) significantly improve the differentiation of breast masses. This imaging technique enhances visualization of vascularity, increasing diagnostic confidence and achieving 100% sensitivity and specificity.
Area of Science:
- Medical imaging
- Radiology
- Oncology
Background:
- Breast masses require accurate diagnostic methods.
- Ultrasound (US) is a common imaging modality for breast lesions.
- Distinguishing benign from malignant breast masses can be challenging.
Purpose of the Study:
- To evaluate a novel microbubble contrast agent for ultrasound.
- To assess the agent's effect on characterizing breast masses.
- To determine if the agent improves diagnostic accuracy.
Main Methods:
- Thirty-four patients with breast masses underwent color Doppler US.
- Intravenous microbubble contrast agent was administered.
- Evaluated Doppler signal intensity, vascular patterns, and transit time.
- Assessed diagnostic confidence before and after contrast administration.
Main Results:
- Cancers showed greater and longer signal enhancement than benign lesions.
- Characteristic vascular features (more vessels, increased tortuosity) were seen in cancers.
- Vascular shunts were present in all cancers, absent in benign lesions.
- Diagnostic confidence and accuracy (sensitivity, specificity) increased to 100%.
Conclusions:
- Microbubble contrast-enhanced ultrasound accurately differentiates benign breast masses from carcinomas.
- The agent provides enhanced visualization of tumor vascularity.
- This technique improves diagnostic performance in breast lesion assessment.